Initial assessment should include a detailed history characterizing the joint symptoms: onset relative to medication initiation, location and pattern of joint involvement, severity and functional impact, aggravating and relieving factors, and any associated symptoms such as swelling, redness, or morning stiffness
But drawing 10 units from one vial delivers twice the medication as drawing 10 units from the other
Tirzepatide has been in clinical use since 2022 and has been studied in over 10,000 participants across multiple trials
Simultaneous inference in general parametric models
Month one is the tolerance-building phase
MMA levels werent measured (Dangour, 2015)